TABLE 7.
ORF (COL) | Gene | Description | Known modulation and characteristics | Reference | Fold changea
|
||||
---|---|---|---|---|---|---|---|---|---|
hemB | CF03 | CF06 | CF07 | CF10 | |||||
Virulence-associated genes | |||||||||
478 | Exotoxin 3 | 6.6 | −3.6 | −2.3 | −6.4b | −6.2 | |||
1168 | fib | Fibrinogen-binding protein | 3.0 | −2.5 | −1.6 | −2.2 | −2.6 | ||
1173 | hla | α-Hemolysin | Up-regulated by Agr; down-regulated by SigB | 9 | 1.8 | −1.6 | −2.4 | −2.2b | −4.3 |
Biosynthesis/transport/metabolism-associated genes | |||||||||
688 | mntC | Manganese ABC transporter, ATP-binding protein | −1.4 | −1.8 | −2.9 | −8.1 | −2.3 | ||
689 | mntB | Manganese ABC transporter, ATP-binding protein | −1.5 | −1.6 | −2.5 | −6.4 | −2.1 | ||
1052 | menD | Carboxylate synthase | −1.2 | −2.8 | −1.8 | −5.0 | −3.1 | ||
1140 | isdA | Heme transport, cell wall LPXTG protein | Down-regulated in biofilm | 7 | 1.9 | −2.8 | −1.7 | −2.5 | −2.1 |
2166 | htsB | Heme transport ABC transporter, permease | −1.0 | −2.9 | −1.5 | −2.7 | −2.3 |
Expression ratios (SCV test strain/Newbould, both strains in the early exponential phase of growth) showing a ≥2-fold decrease in at least three clinical SCVs (but not hemB) are listed. A decrease is indicated by a minus sign.
Calculated with a biological duplicate, not a triplicate like the other values.